PT  - JOURNAL ARTICLE
AU  - Walker, Jessica E
AU  - Oliver, Javon C
AU  - Stewart, Analisa M
AU  - Beh, Suet Theng
AU  - Arce, Richard A
AU  - Glass, Michael J
AU  - Vargas, Daisy E
AU  - Qiji, Sanaria H
AU  - Intorcia, Anthony J
AU  - Borja, Claryssa I
AU  - Cline, Madison P
AU  - Hemmingsen, Spencer J
AU  - Krupp, Addison N
AU  - McHattie, Rylee D
AU  - Mariner, Monica R
AU  - Lorenzini, Ileana
AU  - Aslam, Sidra
AU  - Tremblay, Cecilia
AU  - Beach, Thomas G
AU  - Serrano, Geidy E
TI  - Measuring up: A Comparison of Tapestation 4200 and Bioanalyzer 2100 as Measurement Tools for RNA Quality in Postmortem Human Brain Samples
AID  - 10.1101/2023.07.03.23291969
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.07.03.23291969
4099  - http://medrxiv.org/content/early/2023/07/06/2023.07.03.23291969.short
4100  - http://medrxiv.org/content/early/2023/07/06/2023.07.03.23291969.full
AB  - Determining RNA integrity is a critical quality assessment tool for gene expression studies where the experiment’s success is highly dependent on sample quality. Since its introduction in 1999, the gold standard in the scientific community has been the Agilent 2100 Bioanalyzer’s RNA Integrity Number (RIN) which uses a 1-10 value system with 1 being the most degraded to 10 being the most intact. In 2015, Agilent launched the 4200 Tapestation’s RIN equivalent and reported a strong correlation of r2 of 0.936 and median error < ± 0.4 RIN units. To evaluate this claim, we compared the Agilent 4200 Tapestation’s RIN equivalent (RINe) and DV200 to the Agilent 2100 Bioanalyzer’s RIN for 183 parallel RNA samples. In our study, using RNA from a total of 183 human postmortem brain samples, we found that the RIN and RINe values only weakly correlate with an r2 of 0.393 and an average difference of 3.2 RIN units. DV200 also only weakly correlated with RIN (r2 of 0.182) and RINe (r2 of 0.347). Finally, when applying a cut-off value of 6.5 for both metrics, we found that 95.6% of samples passed with RIN, while only 23.5% passed with RINe. Our results suggest that even though RIN (Bioanalyzer) and RINe (Tapestation) use the same 1-10 value system, they should not be used interchangeably, and cut-off values should be calculated independently.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program has been supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026 National Brain and Tissue Resource for Parkinson's Disease and Related Disorders), the National Institute on Aging (P30 AG19610 and P30AG072980, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05-901 and 1001 to the Arizona Parkinson's Disease Consortium), and the Michael J. Fox Foundation for Parkinson's Research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Western International Review Board name gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors